Exactech announced the first hip resurfacing surgery was using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.
Exactech acquired a minority interest in JointMedica in 2022. Both companies are collaborating to deliver the next generation of hip resurfacing to the global market through the Polymotion implant, which is designated as a Breakthrough Device but has yet to receive clearance from FDA. The implant system will become available in targeted markets on a country-by-country basis following regulatory clearances.
According to Exactech’s Chief Strategy Officer Sharat Kusuma, MD, “Historically, the concept of hip resurfacing has intellectually appealed to surgeons all over the world. In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty]. Sir Charnley’s early hip resurfacings failed due to inferior materials, not due to flaws in the procedure itself.”
Dr. Kusuma continued, “Exactech is thrilled to now partner with the credited inventors of modern hip resurfacing, Derek McMinn MD, FRCS and Ronan Treacy, MD, FRCS, and JointMedica, to deliver the next generation of metal-on-advanced-polyethylene hip resurfacing to the market.”
Exactech announced the first hip resurfacing surgery was using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.
Exactech acquired a minority interest in JointMedica in 2022. Both companies are collaborating to deliver the next generation of hip resurfacing to the global market through the...
Exactech announced the first hip resurfacing surgery was using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.
Exactech acquired a minority interest in JointMedica in 2022. Both companies are collaborating to deliver the next generation of hip resurfacing to the global market through the Polymotion implant, which is designated as a Breakthrough Device but has yet to receive clearance from FDA. The implant system will become available in targeted markets on a country-by-country basis following regulatory clearances.
According to Exactech’s Chief Strategy Officer Sharat Kusuma, MD, “Historically, the concept of hip resurfacing has intellectually appealed to surgeons all over the world. In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty]. Sir Charnley’s early hip resurfacings failed due to inferior materials, not due to flaws in the procedure itself.”
Dr. Kusuma continued, “Exactech is thrilled to now partner with the credited inventors of modern hip resurfacing, Derek McMinn MD, FRCS and Ronan Treacy, MD, FRCS, and JointMedica, to deliver the next generation of metal-on-advanced-polyethylene hip resurfacing to the market.”
Copy to clipboard 
